Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Anticancer drug 5-fluorouracil induces reproductive and developmental defects in Caenorhabditis elegans

8 Mar 2010

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Circadian rhythm and melatonin
Share to Genetics, Aging, and Longevity in Model Organisms
Share to Reproductive Biology and Fertility

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 20206682
DOI: 10.1016/j.reprotox.2010.02.006

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Anticancer drug 5-fluorouracil induces reproductive and developmental defects in Caenorhabditis elegansPMID 20206682Read ↗

Thymidylate synthase and dihydropyrimidine dehydrogenase levels are associated with response to 5-fluorouracil in Caenorhabditis elegans.Semantic proximity Read ↗

Functional analysis of pyrimidine biosynthesis enzymes using the anticancer drug 5-fluorouracil in Caenorhabditis elegans.Semantic proximity Read ↗

Reproductive and developmental toxicities of 5-fluorouracil in model organisms and humansSemantic proximity Read ↗

Isolating genes involved with genotoxic drug response in the nematode Caenorhabditis elegans using genome-wide RNAi screening.Semantic proximity Read ↗

Cell Cycle Analysis in the C. elegans Germline with the Thymidine Analog EdUSemantic proximity Read ↗

Caenorhabditis elegans as an In Vivo Model Organism to Elucidate Teratogenic Effects.Semantic proximity Read ↗

Caenorhabditis elegans as a model system for target identification and drug screening against neurodegenerative diseasesSemantic proximity Read ↗

Caenorhabditis elegans as an emerging high throughput chronotherapeutic drug screening platform for human neurodegenerative disordersSemantic proximity Read ↗

Genetic and cellular sensitivity of <i>Caenorhabditis elegans</i> to the chemotherapeutic agent cisplatinSemantic proximity Read ↗

let-756, a C. elegans fgf essential for worm developmentSemantic proximity Read ↗

Insights into the Phenotypic and Behavioral Effects of Teratogenic Drugs in Caenorhabditis elegans.Semantic proximity Read ↗

Genetic pharmacology: interactions between drugs and gene products in Caenorhabditis elegans.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.